K1833

General

Type : Oxime, Bispyridinium, BODIPY-derivative, Indacen

Chemical_Nomenclature : 4-((2-((4,4-difluoro-4-bora-3a,4a-diaza-s-indacene)amino)ethyl)carbamoyl)-1-(3-(4-((hydroxyimino)methyl)pyridinium-1-yl)propyl)pyridinium dibromide

Canonical SMILES : [N+]1(=CC=C(C=C1)C=NO)CCC[N+]2=CC=C(C=C2)C(NCCNC4=C3[N+](=CC=C3)[B-]([N]5C4=CC=C5)(F)F)=O

InChI : InChI=1S\/C26H26BF2N7O2\/c28-27(29)35-14-1-4-23(35)25(24-5-2-15-36(24)27)30-10-11-31-26(37)22-8-18-34(19-9-22)13-3-12-33-16-6-21(7-17-33)20-32-38\/h1-2,4-9,14-20,30H,3,10-13H2\/p+2

InChIKey : FJMXYWRVAZNAFI-UHFFFAOYSA-P

Other name(s) :


MW :

Formula :

CAS_number :

PubChem :

UniChem : FJMXYWRVAZNAFI-UHFFFAOYSA-P

Target

Structure : No structure

Families : No family

References (1)

Title : BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS - Prchalova_2023_Biomed.Pharmacother_167_115490
Author(s) : Prchalova E , Sukupova M , Malinak D , Andrys R , Sivak L , Pekarik V , Skarka A , Svobodova J , Prchal L , Fresser L , Heger Z , Musilek K
Ref : Biomed Pharmacother , 167 :115490 , 2023
Abstract :
PubMedSearch : Prchalova_2023_Biomed.Pharmacother_167_115490
PubMedID: 37722189